跳至主要内容
临床试验/CTRI/2025/12/098727
CTRI/2025/12/098727招募中不适用

Comparison of Systemic Inflammation and OCT-Based Biomarkers in Patients with Diabetic Macular Edema and Their Role in Predicting Treatment Outcomes After Ranibizumab Injection

Anita Kukreja1 个研究点 分布在 1 个国家目标入组 322 人开始时间: 2025年12月23日最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
322
试验地点
1

研究概览

简要总结

A significant correlation exists between OCT-based biomarkers and systemic inflammatory indices in patients with diabetic macular edema, which may aid in predicting treatment outcomes.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 85.00 Year(s)(—)
性别
All

入选标准

  • confirmed diagnosis of DME with intraretinal fluid or subretinal fluid on OCT.

排除标准

  • previous intraocular surgery within 6 months.

研究者

发起方
Anita Kukreja
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Anita Kukreja

JSS AHER Medical College

研究点 (1)

Loading locations...

相似试验